Amir Steinberg, M.D., has been involved in research focused on lymphoma, quality of care, and nonmalignant transplantation. His clinical focus is on hematologic malignancies and cellular therapy. During his career, Dr. Steinberg has served as the principal investigator (PI) for a study investigating a conditioning regimen called DRBEAT for primary central nervous system lymphoma and was site PI for the multicenter ABVD vs AVD with brentuximab study for advanced-stage Hodgkin lymphoma. He served as PI for transplant studies in Crohn's Disease and site PI for transplant studies for sickle cell anemia and multiple sclerosis. Dr. Steinberg has experience with bloodless transplantation for Jehovah’s Witness patients and has published a protocol on this approach. Dr. Steinberg has been actively involved in the Foundation for the Accreditation of Cellular Therapy (FACT) and is Chair of FACT’s Performance Improvement Committee.

As a high-school senior, he was diagnosed with Hodgkin lymphoma and his experiences and the care he received inspired him to pursue a career in oncology to give back and to treat others and he was treated. He worked at Cedars-Sinai Medical Center and was an assistant professor at UCLA before joining Mount Sinai Hospital's stem cell transplant program in 2011, rising to associate professor. During his 10 years at Mount Sinai, Dr. Steinberg served as the Director of Quality for the transplant program and Transplant Unit Director.

Education of students, residents, fellows, nurse, and colleagues has been an instrumental component to Dr. Steinberg's career. At WMC/NYMC, he has been involved in many aspects of education. Dr. Steinberg first served as the associate program director from 2021-2022 and since 2023 has been the program director for the Hematology-Oncology Fellowship. Dr. Steinberg has worked with the fellows on maximizing their learning experience by having opportunity to supervise fellows, residents, and students in clinic and when he has been on service. Dr. Steinberg has contributed dozens of formal lectures to nurses, students, and fellows on topics in the field of hematologic malignancies since joining WMC/NYMC. What he has most enjoyed is mentoring students and trainees one-on-one through projects and papers.

Education

• B.A., History magna cum laude, University of Texas at Austin
• M.D., Texas Tech University School of Medicine
• Residency, Internal Medicine, St. Luke's-Roosevelt Medical Center
• Fellowship, Hematology-Oncology, Lenox Hill Hospital
• Fellowship, Bone Marrow Transplant, Stanford University

Areas of Expertise

• Lymphoma
• Leukemia
• Myeloma
• Myelodysplastic Syndrome
• Cellular Therapy
• Stem Cell/Bone Marrow Transplantation
• Hematology Oncology

Honors and Awards

• 2023: NYMC Summer Research Program Reward; Westchester Magazine Top Doctor Castle Connolly Medical in Hematology
• 2022: NYMC Summer Research Program Reward; Westchester Magazine Top Doctor Castle Connolly Medical in Hematology
• 2021: NYMC Summer Research Program Reward
• 2020: Contribution in Honor of MD Steinberg; Mount Sinai Office of Development
• 2017-2021: Educator Fellow; Mount Sinai Institute for Medical Education

Memberships and Affiliations

• American College of Physicians
• American Medical Association
• American Society of Hematology
• American Society for Clinical Oncology
• Society of Hematologic Oncology
• Foundation for the Accreditation of Cellular Therapy